ProNoxis AB
556773-2341ActiveDeveloping small molecule drugs targeting NOX2 activation for inflammation treatment.
Overview
- 1
- Employees
- 212K SEK
- Revenue
- 2008
- Founded
Key Decision Makers
Peter Olofsson
Chairman & CEO
Description
ProNoxis is a specialized biotechnology company focused on the preclinical exploration of novel small-molecule therapeutics. Its core mission is developing oral drugs to treat chronic inflammatory, autoimmune, and infectious diseases. The company targets a unique mechanism by developing agonists tha...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556773234101
Decision Makers
1 contacts in FunnelfeedrPeter Olofsson
Chairman & CEO
Similar Companies
20 similar companies in FunnelfeedrRedoxis AB
19 employeesSwedish CRO specializing in preclinical autoimmune and inflammatory disease models.
Inicure AB
0 employeesDeveloping novel small molecules to combat resistant bacterial infections effectively.
Active Biotech AB (publ)
1–4 employeesDeveloping novel treatments for cancer and inflammatory eye diseases.
VACARA AB
2 employeesSwedish biotech developing RA diagnostics, vaccines, and therapeutics.
Novakand Pharma AB
5–9 employeesDeveloping novel small-molecule drugs for inflammation and cancer.
Browse More
ProNoxis AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo